Literature DB >> 18182803

Association between erythropoietin responsiveness and body composition in dialysis patients.

Peter Kotanko1, Stephan Thijssen, Nathan W Levin.   

Abstract

BACKGROUND: In contrast to the general population, in maintenance hemodialysis (MHD) patients, small body size is correlated with reduced survival. The reasons for this association are unclear but may be related to a lower uremic toxin load relative to body weight and a higher distribution volume for uremic toxins in large patients. Since anemia is a salient feature in dialysis patients, this study aimed to explore the relationship between body composition and anemia control.
METHODS: Total adipose tissue (TAT), subcutaneous adipose tissue (SAT) and muscle mass (MM) were estimated by regression models in African-American MHD patients. Patients were grouped for further analysis by gender in tertiles of TAT, SAT, and MM. Analysis of covariance with age and serum albumin as covariates was employed to test for differences in hemoglobin (Hgb, g/dl), erythropoietin use (EPO, U/kg b.w./week), and EPO resistance index (ERI, U/kg b.w./week/Hgb).
RESULTS: 479 patients were studied (50.5% females). In both genders, EPO dose and ERI were lower the higher the tertile of TAT and SAT (all p < 0.02). In females, EPO and ERI were inversely related to tertiles of MM (p <or= 0.001). No difference in Hgb concentration was observed.
CONCLUSION: Anemia control is related to body composition in Black dialysis patients. EPO requirements and EPO resistance are reduced in patients with high TAT, SAT and MM (the latter in females only). A lower uremic load in large dialysis patients may contribute to these findings. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182803     DOI: 10.1159/000110571

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  11 in total

Review 1.  Leptin in chronic kidney disease: a link between hematopoiesis, bone metabolism, and nutrition.

Authors:  Jingjing Zhang; Ningning Wang
Journal:  Int Urol Nephrol       Date:  2013-12-14       Impact factor: 2.370

2.  [Why do obese dialysis patients live longer--a hypothesis].

Authors:  Peter Kotanko; Martin K Kuhlmann; Nathan W Levin
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

3.  How Is Body Composition and Nutrition Status Associated with Erythropoietin Response in Hemodialyzed Patients? A Single-Center Prospective Cohort Study.

Authors:  Wiktoria Feret; Krzysztof Safranow; Kazimierz Ciechanowski; Ewa Kwiatkowska
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

4.  Assessment of body composition in dialysis patients by arm bioimpedance compared to MRI and 40K measurements.

Authors:  M Carter; F Zhu; P Kotanko; M Kuhlmann; L Ramirez; S B Heymsfield; G Handelman; N W Levin
Journal:  Blood Purif       Date:  2009-03-09       Impact factor: 2.614

5.  Analysis of the correlation between serum resistin and the variability of erythropoietin responsiveness in patients with chronic kidney disease.

Authors:  Honghao Zhang; Xiujiang Li; Yanhong Kan; Fan Yang; Yue Hou; Yujun DU
Journal:  Exp Ther Med       Date:  2015-09-23       Impact factor: 2.447

6.  Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice.

Authors:  Kazuki Kodo; Satoru Sugimoto; Hisakazu Nakajima; Jun Mori; Ikuyo Itoh; Shota Fukuhara; Keiichi Shigehara; Taichiro Nishikawa; Kitaro Kosaka; Hajime Hosoi
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

7.  Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients.

Authors:  Tomoaki Takata; Yukari Mae; Kentaro Yamada; Sosuke Taniguchi; Shintaro Hamada; Marie Yamamoto; Takuji Iyama; Hajime Isomoto
Journal:  BMC Nephrol       Date:  2021-04-16       Impact factor: 2.388

8.  Factors Contributing to Erythropoietin Hyporesponsiveness in Patients on Long-Term Continuous Ambulatory Peritoneal Dialysis: A Cross-Sectional Study.

Authors:  Takashi Hara; Hideyuki Mukai; Takafumi Nakashima; Rikako Sagara; Masahide Furusho; Shuhei Miura; Jiro Toyonaga; Koji Sugawara; Kazuhito Takeda
Journal:  Nephron Extra       Date:  2015-10-28

9.  Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up.

Authors:  Jolanta Malyszko; Maciej Drozdz; Agnieszka Zolkiewicz; Boleslaw Rutkowski
Journal:  Int Urol Nephrol       Date:  2012-11-08       Impact factor: 2.370

10.  Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study.

Authors:  E J F Santos; E V Hortegal; H O Serra; J S Lages; N Salgado-Filho; A M Dos Santos
Journal:  Braz J Med Biol Res       Date:  2018-05-07       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.